化合物 SD-208|T2109

SD-208
627536-09-8

￥177 1mg 起订

￥246 2mg 起订

￥392 5mg 起订

上海更新日期：2024-09-14

TargetMol中国（陶术生物）

VIP12年

联系人：邵小姐

电话：021-021-33632979拨打

手机：15002134094 拨打

邮箱：marketing@targetmol.com

产品详情:

中文名称：: 化合物 SD-208

英文名称：: SD-208

CAS号：: 627536-09-8

品牌：: TargetMol

产地：: 美国

保存条件：: Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.

纯度规格：: ≥95%

产品类别：: 抑制剂

货号：: T2109

Product Introduction

Bioactivity

Name	SD-208
Description	SD-208 (ALK5 Inhibitor V), a selective TGF-βRI (ALK5) inhibitor (IC50: 48 nM), is >100-fold selectivity over TGF-βRII.
Cell Research	Glioma cells are cultured in the absence or presence of SD-208 (1 μM) for 48 hours. The cells are pulsed for the last 24 hours with [methyl-3H]thymidine (0.5 μCi) and harvested, and incorporated radioactivity is determined in a liquid scintillation counter.(Only for Reference)
Kinase Assay	Kinase assay: Various kinase activities are assayed by measuring the incorporation of radiolabeled ATP into a peptide or protein substrate. The reactions are performed in 96-well plates and included the relevant kinase, substrate, ATP, and appropriate cofactors. The reactions are incubated and then stopped by the addition of phosphoric acid. Substrate is captured onto a phosphocellulose filter, which is washed free of unreacted ATP. The counts incorporated are determined by counting on a microplate scintillation counter. The ability of SD-208 to inhibit the respective kinase is determined by comparing counts incorporated in the presence of compound with those incorporated in the absence of compound.
In vitro	SD-208（1 mg/mL,p.o.）使负荷SMA-560胶质瘤小鼠的中值存活率显著延长.在同源129S1小鼠体内,SD-208（60 mg/kg,p.o.）抑制初级R3T肿瘤生长,并使肺转移的数量及大小减少.在小鼠大动脉同种移植模型中,SD-208可有效减少移植动脉硬化内膜增生的形成.
In vivo	在体外,SD-208阻断TGF-β诱导的受体相关Smads,Smad/3磷酸化,且对上皮细胞到间叶细胞的分化转化、迁移及侵袭到基底膜具有刺激作用。在体外,SD-208还可阻断TGF-β对新生内膜平滑肌样细胞迁移与增殖的保护作用。在小鼠SMA-560和人SMA-560胶质瘤细胞中,SD-208抑制细胞生长、组成及转化生长因子-β诱发的迁移和浸润,并使免疫原性增强。
Storage	Powder: -20°C for 3 years \| In solvent: -80°C for 1 year \| Shipping with blue ice.
Solubility Information	DMSO : 7.1 mg/mL (20 mM), Heating is recommended.
Keywords	inhibit \| Transforming growth factor beta receptors \| TGF-β Receptor \| Inhibitor \| SD 208 \| SD-208
Inhibitors Related	Monocrotaline \| Pirfenidone \| RepSox \| A 83-01 \| Halofuginone \| Chromenone 1 \| LY-364947 \| BMP signaling agonist sb4 \| SB-431542 \| Galunisertib \| Alantolactone \| LDN-193189 2HCl
Related Compound Libraries	Inhibitor Library \| Anti-Cancer Active Compound Library \| Bioactive Compound Library \| Bioactive Compounds Library Max \| Anti-Cardiovascular Disease Compound Library \| Highly Selective Inhibitor Library \| Anti-Ovarian Cancer Compound Library \| Anti-Obesity Compound Library \| TGF-beta/Smad Compound Library \| Tyrosine Kinase Inhibitor Library

SD208|||ALK5 Inhibitor V|TargetMol

上海陶术生物科技有限公司为美国Target Molecule Corp. ( Target Mol ) 在上海建立的全资子公司。我们与美国波士顿、德国慕尼黑的同事一起，为北美、欧洲和亚洲从事药物研发和生物学研究的科学家提供优质的产品和专业的服务。公司下设筛选事业部，化学事业部，生物事业部和新材料部。从虚拟筛选到实体化合物分子供应；从商业化产品销售到个性化定制合成；从对明确靶点的分子筛选到对明确分子的多靶点筛选，从高通量筛选到化学结构优化，我们都可以满足您的科研用品及技术服务的需求。经过在中国市场五年的精心耕耘，我们已成为筛选化合物领域优秀的供应商，为超过五百家学校和各类企业提供了品质卓越的小分子化合物和药物筛

成立日期	(12年)
注册资本	566.2651万人民币
员工人数	100-500人
年营业额	￥ 1亿以上
经营模式	贸易,试剂,定制,服务
主营行业	化学试剂,生物活性小分子